| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |